Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

被引:4
|
作者
Araujo, Nathalia [1 ]
Sledziona, James [1 ]
Noothi, Sunil K. [2 ]
Burikhanov, Ravshan [3 ]
Hebbar, Nikhil [1 ]
Ganguly, Saptadwipa [1 ]
Shrestha-Bhattarai, Tripti [4 ]
Zhu, Beibei [5 ,6 ]
Katz, Wendy S. [6 ,7 ]
Zhang, Yi [8 ]
Taylor, Barry S. [4 ]
Liu, Jinze [8 ]
Chen, Li [5 ,9 ]
Weiss, Heidi L. [5 ,9 ]
He, Daheng [10 ]
Wang, Chi [9 ,11 ]
Morris, Andrew J. [5 ,9 ]
Cassis, Lisa A. [6 ,7 ]
Nikolova-Karakashian, Mariana [9 ,12 ]
Nagareddy, Prabhakar R. [13 ]
Melander, Olle [14 ,15 ]
Evers, B. Mark [9 ,16 ]
Kern, Philip A. [5 ,6 ]
Rangnekar, Vivek M. [1 ,2 ,3 ,9 ]
机构
[1] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA
[2] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA
[3] Univ Kentucky, Dept Radiat Med, Lexington, KY 40506 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
[5] Univ Kentucky, Div Internal Med, Lexington, KY USA
[6] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Lexington, KY USA
[7] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA
[8] Univ Kentucky, Dept Comp Sci, Lexington, KY USA
[9] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA
[10] Univ Kentucky, Dept Stat, Lexington, KY USA
[11] Univ Kentucky, Dept Biostat, Lexington, KY USA
[12] Univ Kentucky, Dept Physiol, Lexington, KY USA
[13] Ohio State Univ, Div Cardiac Surg, Columbus, OH 43210 USA
[14] Lund Univ, Dept Cir Sci, Malmo, Sweden
[15] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden
[16] Univ Kentucky, Dept Surg, Lexington, KY USA
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
hypertrophic obesity; adipocyte tissue storage; fat absorption; acylation stimulating protein; C3; Par-4; ACYLATION-STIMULATING PROTEIN; LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; ENERGY-EXPENDITURE; CELL APOPTOSIS; IN-VITRO; P53; PATHWAY; IDENTIFICATION; HYPERTROPHY;
D O I
10.3389/fonc.2022.860446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate apoptosis response-4 (Par-4) is a tumor suppressor that induces apoptosis in cancer cells. However, the physiological function of Par-4 remains unknown. Here we show that conventional Par-4 knockout (Par-4(-/-)) mice and adipocyte-specific Par-4 knockout (AKO) mice, but not hepatocyte-specific Par-4 knockout mice, are obese with standard chow diet. Par-4(-/-) and AKO mice exhibit increased absorption and storage of fat in adipocytes. Mechanistically, Par-4 loss is associated with mdm2 downregulation and activation of p53. We identified complement factor c3 as a p53-regulated gene linked to fat storage in adipocytes. Par-4 re-expression in adipocytes or c3 deletion reversed the obese mouse phenotype. Moreover, obese human subjects showed lower expression of Par-4 relative to lean subjects, and in longitudinal studies, low baseline Par-4 levels denoted an increased risk of developing obesity later in life. These findings indicate that Par-4 suppresses p53 and its target c3 to regulate obesity.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer
    Nagai, Maria Aparecida
    Gerhard, Rene
    Salaorni, Sibeli
    Tavares Guerreiro Fregnani, Jose Humberto
    Nonogaki, Suely
    Netto, Mario Mourao
    Soares, Fernando Augusto
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (01) : 41 - 49
  • [32] Complement Component 3 (C3) Participates in Induction of Myeloid Suppressor Cells.
    Hsieh, C.
    Chou, H.
    Wang, L.
    Lin, F.
    Qin, J.
    Fung, J.
    Lu, L.
    Qian, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 487 - 487
  • [33] Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H
    Muehlig, Anne K.
    Keir, Lindsay S.
    Abt, Jana C.
    Heidelbach, Hannah S.
    Horton, Rachel
    Welsh, Gavin I.
    Meyer-Schwesinger, Catherine
    Licht, Christoph
    Coward, Richard J.
    Fester, Lars
    Saleem, Moin A.
    Oh, Jun
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [34] Molecular Characterization of Complement Components (C3, C4, and Factor B) in Human Saliva
    Akira Andoh
    Yoshihide Fujiyama
    Toshio Kimura
    Hirotugu Uchihara
    Hitoshi Sakumoto
    Hidetoshi Okabe
    Tadao Bamba
    Journal of Clinical Immunology, 1997, 17 : 404 - 407
  • [35] Molecular characterization of complement components (C3, C4, and factor B) in human saliva
    Andoh, A
    Fujiyama, Y
    Kimura, T
    Uchihara, H
    Sakumoto, H
    Okabe, H
    Bamba, T
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (05) : 404 - 407
  • [36] C3 Glomerulonephritis Associated With Complement Factor B Mutation
    Sethi, Sanjeev
    Smith, Richard J. H.
    Dillon, John J.
    Fervenza, Fernando C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (03) : 520 - 521
  • [37] Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells
    Mogilenko, Denis A.
    Kudriavtsev, Igor V.
    Shavva, Vladimir S.
    Dizhe, Ella B.
    Vilenskaya, Ekaterina G.
    Efremov, Alexander M.
    Perevozchikov, Andrej P.
    Orlov, Sergey V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (03) : 1726 - 1738
  • [38] IgM autoantibodies to complement factor H in C3 glomerulopathy
    Cugno, Massimo
    Mancuso, Maria Cristina
    Depetri, Federica
    Peyvandi, Flora
    Ardissino, Gianluigi
    JOURNAL OF NEPHROLOGY, 2024, 37 (05) : 1415 - 1416
  • [39] Complement C3: an emerging risk factor in cardiometabolic disease
    E. Hertle
    M. M. J. van Greevenbroek
    C. D. A. Stehouwer
    Diabetologia, 2012, 55 : 881 - 884
  • [40] C3 Glomerulonephritis With Multiple Mutations in Complement Factor H
    Dalili, Nooshin
    Behnam, Babak
    Vali, Farzaneh
    Parvin, Mahmoud
    Torbati, Peyman
    Rasaii, Nakisa
    Samadian, Fariba
    Ahmadboor, Pedram
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (06) : 376 - 381